Table 5.

SVR outcomes based on the hepatitis C genotype.

Hepatitis C genotype	GI clinic (noncirrhotic) Group-1 (n = 192)	PCP clinic (noncirrhotic) Group-2 (n = 185)	p value	n (%) of patients achieving SVR in GI clinic for the genotype	n (%) of patients achieving SVR in PCP clinic for the genotype
1a, n (%)	112 (58.33)	113 (61.08)	<0.01	108 (96.43)	105 (92.92)
1b, n (%)	32 (16.67)	50 (27.03)		31 (96.88)	47 (94.00)
2b, n (%)	25 (13.02)	12 (6.49)		25 (100)	11 (91.67)
2, n (%)	8 (4.17)	1 (0.54)		8 (100)	1 (100)
4, n (%)	4 (2.08)	0		4 (100)	0
3a, n (%)	3 (1.56)	3 (1.62)		2 (66.67)	3 (100)
1, n (%)	3 (1.56)	0		2 (66.67)	0
2a/2c, n (%)	2 (1.04)	2 (1.08)		2 (100)	2 (100)
3, n (%)	2 (1.04)	0		1 (50.00)	0
1a/1b, n (%)	1 (0.52)	2 (1.08)		1 (100)	2 (100)
2b & 3, n (%)	0	1 (0.54)		0	1 (100)
4a/4c/4d, n (%)	0	1 (0.54)		0	1 (100)

Abbreviations: GI: gastroenterology; PCP: primary care physician; SVR: sustained virological response.